drugset / Trial / NCT01593306

Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma Cervix

NCT01593306 ↗

Phase 3 Unknown 80 enrolled Indira Gandhi Medical College, Shimla
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to check whether addition of paclitaxel to cisplatin and radiation therapy will improve the outcome in locally advanced carcinoma cervix.

Timeline

Start
2011-07
Primary completion
2012-10
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cisplatin Other / unclassified 30 mg/m2 Intravenous
Comparator Cisplatin Other / unclassified 40 mg/m2 Intravenous
Subject Paclitaxel Small molecule 50 mg/m2 Intravenous

Indications